.
MergerLinks Header Logo

New Deal


Announced

Completed

Mubadala led a $150m Series E round in Innovaccer.

Financials

Edit Data
Transaction Value£113m
Consideration TypeCash
Capital Owned-
Capital Bid For5%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

healthcare technology

Cross Border

Single Bidder

United States

Minority

Venture Capital

IT Services: Other

Friendly

Completed

Private

Private Equity

Acquisition

Synopsis

Edit

Mubadala led a $150m Series E round in Innovaccer, a San Francisco-based healthcare technology company, with participation from B Capital Group, M12, OMERS Growth Equity, Dragoneer, Steadview Capital, Tiger Global Management, Whale Rock Capital Management, Avidity Partners and Schonfeld Strategic Advisors. "We’ve reached a turning point in healthcare, where the world of fragmented, fee-for-service ‘sick care’ is giving way to a new world of integrated, value-based, preventive care. The electronic health record (EHR) brought healthcare into the digital world, but in many ways it has become an impediment to digital transformation due to its rigid architecture and lack of interoperability. Providers, payers, and life sciences companies recognize the urgent need for a new, open platform that brings all healthcare data together to provide a singular view of the patient, and enables friction-free care across the entire patient journey. This is the future of health everyone wants, and this is exactly what we are building with the Innovaccer Health Cloud," Abhinav Shashank, Innovaccer CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US